Epub – NPJ Schizophrenia
MAP2 Immunoreactivity Deficit is Conserved Across the Cerebral Cortex Within Individuals with Schizophrenia

August 28, 2019

Several postmortem studies have reported lower levels of immunoreactivity (IR) for microtubule-associated protein 2 (MAP2) in several cortical regions of individuals with schizophrenia (SZ). However, whether this effect is conserved across multiple brain areas within an individual with SZ or if it is regionally-specific remains unclear. We characterized patterns of MAP2-IR across three cortical regions at different levels of the rostral-caudal axis within individual subjects with and without SZ. MAP2-IR levels were measured in deep layer 3 of dorsolateral prefrontal cortex (DLPFC), lateral intraparietal cortex (LIP), and primary visual cortex (V1). Postmortem tissue containing each cortical region was derived from 20 pairs of SZ subjects and nonpsychiatric comparison (NPC) subjects matched perfectly for sex, and as closely as possible for age and postmortem interval. MAP2-IR was assessed by quantitative fluorescence microscopy. We observed significantly lower levels of MAP2-IR in SZ subjects relative to NPC subjects, without a significant region by diagnosis interaction. Logs of the within-pair ratios (SZ:NPC) of MAP2-IR were significantly correlated across the three regions. These findings demonstrate that MAP2-IR deficits in SZ are consistent across three neocortical regions within individual subjects. This pattern of MAP2-IR deficit has implications for therapeutic development and future investigations of MAP2 pathology in SZ.

DeGiosio R, Kelly RM, DeDionisio AM, Newman JT, Fish KN, Sampson AR, Lewis DA, Sweet RA. MAP2 Immunoreactivity Deficit is Conserved Across the Cerebral Cortex Within Individuals with Schizophrenia. NPJ Schizophr. 2019 Aug 28;5(1):13. doi: 10.1038/s41537-019-0081-0. PubMed PMID: 31462659, PMCID: PMC6713711.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713711/

Translational Neuroscience Program

Understanding the Brain
to Improve Mental Health

 

 

 

 

© 2020 University of Pittsburgh

            a

Assistant Director
slovsl@upmc.edu

            a

University of Pittsburgh
3811 O'Hara Street, BST W1651
Pittsburgh, PA 15213

            a

University of Pittsburgh
Department of Psychiatry

W1651 Biomedical Science Tower
203 Lothrop Street
Pittsburgh, PA 15213

Bridgeside Point II, Suite 223
450 Technology Drive
Pittsburgh, PA 15219

a

412-624-3894